Development and Validation of MMPI-2-RF Scales for Indexing Triarchic Psychopathy Constructs. (October 2016)

• Record Type: Journal Article
• Authors: Sellbom, Martin; Drislane, Laura E.; Johnson, Alexandria K.; Goodwin, Brandee E.; Phillips, Tasha R.; Patrick, Christopher J.
• Is Part Of: Assessment. Volume 23:Number 5(2016:Oct.)
• Page Start: 527
• Page End: 543
• Publication Date: 2016-10
• Subjects: MMPI-2-RF -- psychopathy -- triarchic -- personality assessment; Psychological tests -- Periodicals; Psychodiagnostics -- Periodicals; Personality tests -- Periodicals; 150.287
• DOI: 10.1177/1073191115590853
• Languages: English
• ISSNs: 1073-1911

Abstract

The triarchic model characterizes psychopathy in terms of three distinct dispositional constructs of boldness, meanness, and disinhibition. The model can be operationalized through scales designed specifically to index these domains or by using items from other inventories that provide coverage of related constructs. The present study sought to develop and validate scales for assessing the triarchic model domains using items from the Minnesota Multiphasic Personality Inventory–2–Restructured Form (MMPI-2-RF). A consensus rating approach was used to identify items relevant to each triarchic domain, and following psychometric refinement, the resulting MMPI-2-RF-based triarchic scales were evaluated for convergent and discriminant validity in relation to multiple psychopathy-relevant criterion variables in offender and nonoffender samples. Expected convergent and discriminant associations were evident very clearly for the Boldness and Disinhibition scales and somewhat less clearly for the Meanness scale. Moreover, hierarchical regression analyses indicated that all MMPI-2-RF triarchic scales incremented standard MMPI-2-RF scale scores in predicting extant triarchic model scale scores. The widespread use of MMPI-2-RF in clinical and forensic settings provides avenues for both clinical and research applications in contexts where traditional psychopathy measures are less likely to be administered.